Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials. - Université de Lille Accéder directement au contenu
Article Dans Une Revue (Article De Synthèse) European Journal of Clinical Pharmacology Année : 2020

Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials.

Farhad Pazan
  • Fonction : Auteur
Antonio Cherubini
  • Fonction : Auteur
Alfonso J. Cruz-Jentoft
  • Fonction : Auteur
Thomas Frühwald
  • Fonction : Auteur
Alberto Pilotto
  • Fonction : Auteur
Elina Rönnemaa
  • Fonction : Auteur
George Soulis
  • Fonction : Auteur
Alpana Mair
  • Fonction : Auteur
Heinrich Burkhardt
  • Fonction : Auteur
Martin Wehling
  • Fonction : Auteur

Résumé

Background Frailty and adverse drug effects are linked in the fact that polypharmacy is correlated with the severity of frailty; however, a causal relation has not been proven in older people with clinically manifest frailty. Methods A literature search was performed in Medline to detect prospective randomized controlled trials (RCTs) testing the effects of pharmacological interventions or medication optimization in older frail adults on comprehensive frailty scores or partial aspects of frailty that were published from January 1998 to October 2019. Results Twenty-five studies were identified, 4 on comprehensive frailty scores and 21 on aspects of frailty. Two trials on comprehensive frailty scores showed positive results on frailty although the contribution of medication review in a multidimensional approach was unclear. In the studies on aspects related to frailty, ten individual drug interventions showed improvement in physical performance, muscle strength or body composition utilizing alfacalcidol, teriparatide, piroxicam, testosterone, recombinant human chorionic gonadotropin, or capromorelin. There were no studies examining negative effects of drugs on frailty. Conclusion So far, data on a causal relationship between drugs and frailty are inconclusive or related to single-drug interventions on partial aspects of frailty. There is a clear need for RCTs on this topic that should be based on a comprehensive, internationally consistent and thus reproducible concept of frailty assessment.
Fichier principal
Vignette du fichier
s00228-020-02951-8.pdf (416.27 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04327468 , version 1 (07-12-2023)

Licence

Identifiants

Citer

Farhad Pazan, Mirko Petrovic, Antonio Cherubini, Graziano Onder, Alfonso J. Cruz-Jentoft, et al.. Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials.. European Journal of Clinical Pharmacology, 2020, European Journal of Clinical Pharmacology, ⟨10.1007/s00228-020-02951-8⟩. ⟨hal-04327468⟩

Collections

UNIV-LILLE
7 Consultations
3 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More